Vancouver, BC -- (SBWIRE) -- 01/22/2021 -- The global immunotherapy drugs market is projected to reach USD 365.57 Billion by 2027, at a CAGR of 12.1% during the forecast period, according to a recent report by Emergen Research. Growing preference of patients for personalized treatments over conventional treatment methods will fuel the market growth during the forecast period. The higher incidence of cancer is another driving factor for the market growth.

In the immunotherapy drugs market, the cancer segment is expected to hold the largest market share during the forecast period. The increasing incidence of cancer, rise in research activity in this field, and insurance availability for oncology immunotherapies are factors driving the segment.

Interested in this Immunotherapy Drugs market report? Get your FREE sample now! https://www.emergenresearch.com/request-sample-form/417

Key market participants include Sanofi S.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., AstraZeneca plc, BioNTech SE, Gilead Sciences, Inc., Incyte Corporation, bluebird bio, Inc., Genmab A/S, and Bayer AG

Market Drivers

High mortality rate of cancer is the primary factor driving the global immunotherapy market growth during the forecast period. Change in lifestyles of the people has led to several disorders, such as hypertension, obesity, diabetes, which require intensive care. Thus, the higher prevalence of such lifestyle-related disorders is expected to boost the market's immunotherapy drugs market during the forecast period.

Drug Type Outlook (Revenue, USD Billion; 2017–2027)
Checkpoint Inhibitors
Monoclonal Antibodies
Vaccines
Interleukins
Interferons Alpha and Beta
Others

Therapeutic Area Outlook (Revenue, USD Billion; 2017–2027)
Infectious Diseases
Autoimmune & Inflammatory Diseases
Cancer
Others

End-user Outlook (Revenue, USD Billion; 2017–2027)
Clinics
Research Centers
Hospitals
Others

The monoclonal antibodies type of immunotherapy drugs is expected to face the highest growth during the forecast period. These provide better protection against the disease and help boost the immune system by boosting the antibodies' reproduction rate.

Directly Purchase/Place an Order for a copy of this research report at: https://www.emergenresearch.com/select-license/417

Regional Analysis

Due to the high incidence of cancer and the highly advanced healthcare sector, North America is expected to dominate the global market during the forecast period. The Asia Pacific market is projected to grow with the highest CAGR during the forecast period, owing to the growth of the number of cancer patients in the region and growing awareness among consumers in the region regarding advanced cancer treatment.

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Immunotherapy Drugs Market Segmentation & Impact Analysis

    4.1. Immunotherapy Drugs Market Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. The increasing global cancer incidence

                    4.2.2.2. The growing demand for monoclonal antibodies

                    4.2.2.3. The rising advent of Biologics

                    4.2.2.4. Increasing adoption of personalized treatment over conventional treatment

          4.2.3. Market restraints analysis

                    4.2.3.1. Higher immunotherapy drug price

                    4.2.3.2. High rate of attrition in the phase of production process

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter's Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Chapter 5. Immunotherapy Drugs Market By Drug Type Insights & Trends, Revenue (USD Billion) 

    5.1. Drug Type Dynamics & Market Share, 2019 & 2027

          5.1.1. Checkpoint Inhibitors

          5.1.2. Monoclonal Antibodies

          5.1.3. Vaccines

          5.1.4. Interleukins

          5.1.5. Interferons Alpha and Beta

          5.1.6. Others

Chapter 6. Immunotherapy Drugs Market By Therapeutic Area Insights & Trends Revenue (USD Billion) 

    6.1. Therapeutic Area Dynamics & Market Share, 2019 & 2027

          6.1.1. Infectious Diseases

          6.1.2. Autoimmune & Inflammatory Diseases

          6.1.3. Cancer

          6.1.4. Others

Chapter 7. Immunotherapy Drugs Market By End User Insights & Trends Revenue (USD Billion) 

    7.1. End User Dynamics & Market Share, 2019 & 2027

          7.1.1. Clinics

          7.1.2. Research Centers

          7.1.3. Hospitals

          7.1.4. Others

Continue…!

Browse complete report description and visit our website @ https://www.emergenresearch.com/industry-report/immunotherapy-drugs-market